Oral Docosahexaenoic Acid in the Prevention of Exudative Age-Related Macular Degeneration: The Nutritional AMD Treatment 2 Study
Objective: To evaluate the efficacy of docosahexaenoic acid (DHA)–enriched oral supplementation in preventing exudative age-related macular degeneration (AMD).Design: The Nutritional AMD Treatment 2 study was a randomized, placebo-controlled, double-blind, parallel, comparative study.Participants: Two hundred sixty-three patients 55 years of age or older and younger than 85 years with early lesions of age-related maculopathy and visual acuity better than 0.4 logarithm of minimum angle of resolution units in the study eye and neovascular AMD in the fellow eye.Methods: Patients were assigned randomly to receive either 840 mg/day DHA and 270 mg/day (Read more...)